Mr Tevita Aho

Tev moved from New Zealand to the UK to do a Uro-oncology Fellowship at Cambridge University Hospitals NHS Foundation Trust in 2003. During his training in NZ he spent a year learning Holmium Laser Enucleation of the Prostate (HoLEP) from the urologists who invented it (Peter Gilling and Mark Fraundorfer). In 2004, Tev introduced HoLEP to Cambridge which was one of the first UK centres to offer it. Tev is the most experienced HoLEP surgeon in the UK, and has performed more than 4,500 HoLEP procedures. He developed the TEV Technique for enbloc HoLEP and also a HoLEP technique for sparing ejaculatory function (Ejaculation-sparing HoLEP). He is frequently invited to lecture on HoLEP in the UK and abroad and has convened annual HoLEP courses in Cambridge since 2005. Since 2015 he has also worked at the Princess Grace Hospital in London. Tev was the founding President of the UK Holmium User Group (HUG). He designed and implemented the national HUG Training Programme for HoLEP, and has mentored many surgeons in HoLEP. Tev has been involved in HoLEP research from its earliest days, and has published and presented widely on the subject. Tev was one of the first british urologists to perform Aquablation in the UK in 2016 as an investigator for the first WATER Study. He offers a full portfolio of treatments for men with bothersome urinary symptoms and/or urinary retention due to Benign Prostatic Hyperplasia, and enjoys offering a bespoke service aimed at designing the most appropriate treatment plan for each individual patient he cares for. BPH treatments that Tev offers include: conservative measures, medical treatments, and procedures such as Urolift, Rezum, laser bladder neck incision, Aquablation, HoLEP and ejaculation-sparing HoLEP.

Male Lower Urinary Tract Symptoms and male urinary retention due to Benign Prostatic Hyperplasia (BPH) Procedures for BPH including HoLEP, Ejaculation-sparing HoLEP, Rezum, Urolift, Aquablation